IL-7Rα and KLRG-1 surface markers were used to differentiate the two stages of T cell differentiation at the effector phase of the anti-tumor response: short-lived effector cells (SLECs) and memory precursor effector cells (MPECs) (13, 45, 46). This evidence concerns the gene IL7R and neoplasm.